BDX Becton Dickinson Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
23:44
May 07
May 07
BD strong quarter, AI healthcare growth.
Becton Dickinson reported a strong quarter with a top and bottom line beat, raised full-year earnings guidance, and has a portfolio that is 90% recurring revenue. The company is benefiting from AI in healthcare (patient monitoring), GLP-1 injectables, tissue regeneration, and home care solutions, making it a compelling investment.
HIGH
22:45
Apr 11
Apr 11
BDX is a scarce asset with margin of safety.
Becton Dickinson (BDX) is a world leader in syringes and catheters with over 50% market share, giving it scale economies, embeddedness in hospital systems, and a regenerative feedback loop for innovation. It trades at 12-13 times earnings (8% earnings yield), implying the market expects little growth, yet the company is focused, generates strong free cash flow, and uses it for dividends and buybacks. It is well-positioned to benefit from the growth of biologics and integration of technology like AI.
HIGH
About BDX Analyst Coverage
Buzzberg tracks BDX (Becton Dickinson) across 2 sources. 2 bullish vs 0 bearish calls from 2 analysts. Sentiment: predominantly bullish (100%). 2 total trade ideas tracked.